Large national survey suggests that the use of psychedelics is not associated with lifetime cancer development
When controlling for confounding variables, the results revealed that lifetime psychedelic use was not associated with lifetime cancer diagnosis nor hematologic cancer diagnosis. This was true for each of the three classifications of psychedelics: tryptamine (5-MeO-DIPT, AMT, DMT), lysergamide (LSD), and phenethylamine (2C-B, mescaline, MDMA, peyote, and San Pedro). “Beginning in the late 1960s, concerns were raised by laboratory experiments that…
Recent Comments